Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
Clinical trial NCT00135369 · COMPLETED
Trial details
- NCT number
- NCT00135369
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2005-07-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.